Less Ads, More Data, More Tools Register for FREE

Pin to quick picksM P Evans Regulatory News (MPE)

Share Price Information for M P Evans (MPE)

Share Price is delayed by 15 minutes
Get Live Data
1,512.00    -38.00 (-2.45%)
Bid:
1,510.00
Ask:
1,514.00
Spread: 4.00 (0.265%)
Market Cap: £788.72m
MPE Live PriceLast checked at - London Stock Exchange

Intraday M P Evans Share Chart

Director/PDMR Shareholding

16 Dec 2025 07:00

RNS Number : 6553L
M. P. Evans Group PLC
16 December 2025
 

M.P. EVANS GROUP PLC

("Company" or "M.P. Evans")

 

GRANT OF SHARE OPTIONS

 

On 15 December 2025, in line with its policy of deferring half the executive annual bonus into nil-cost share options, the Company granted an option under the M.P. Evans Group PLC Long Term Incentive Scheme to each of Mr Matthew Coulson, the chief executive, and Mr Luke Shaw, the chief financial officer. They may subscribe for 15,119 and 10,134 shares of 10p each respectively in the Company at a nil cost exercise price. No additional performance criteria will attach to the deferred-bonus awards since the original bonuses are performance related. These options are exercisable at any time between 15 December 2028 and 14 December 2035.

 

The information set out below is provided in accordance with the requirements of Article 19(3) of Regulation (EU) No. 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse, as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018, as amended ("UK MAR").

 

1

Details of the persons discharging managerial responsibilities / person closely associated

a)

Name

Matthew Coulson

2

Reason for the notification

a)

Position/status

Chief executive

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

M.P. Evans Group PLC

b)

LEI

2138003IBXJUCR4SZG26

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Shares of 10p per share in the capital of M.P. Evans Group PLC (10p shares)

Identification code

ISIN: GB0007538100

b)

Nature of the transaction

Grant of options over 10p shares

c)

Price(s) and volume(s)

Exercise Prices per share

Volume

Nil Cost Options

15,119

d)

Aggregated information

- Aggregated volume

- Price

 

Aggregated volume: N/A

Price: N/A

e)

Date of the transaction

15 December 2025

f)

Place of the transaction

Outside a trading venue

 

1

Details of the persons discharging managerial responsibilities / person closely associated

a)

Name

Luke Shaw

2

Reason for the notification

a)

Position/status

Chief financial officer

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

M.P. Evans Group PLC

b)

LEI

2138003IBXJUCR4SZG26

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Shares of 10p per share in the capital of M.P. Evans Group PLC (10p shares)

Identification code

ISIN: GB0007538100

b)

Nature of the transaction

Grant of options over 10p shares

c)

Price(s) and volume(s)

Exercise Prices per share

Volume

Nil Cost Options

10,134

d)

Aggregated information

- Aggregated volume

- Price

 

Aggregated volume: N/A

Price: N/A

e)

Date of the transaction

15 December 2025

f)

Place of the transaction

Outside a trading venue

 

16 December 2025

Enquiries:

 

M.P. Evans Group PLC

Telephone: +44 (0) 1892 516333

Peter Hadsley-Chaplin, chairman

Matthew Coulson, chief executive

Luke Shaw, chief financial officer

Cavendish Capital Markets (Nomad and joint broker)

Telephone: +44 (0) 20 7220 0500

Matt Goode, George Lawson (Corporate finance)

Tim Redfern, Harriet Ward (ECM)

Canaccord Genuity Limited (Joint broker)

Telephone: +44 (0) 20 7523 4500

Henry Fitzgerald-O'Connor, George Grainger

Hudson Sandler (Financial PR)

Telephone: +44 (0) 20 7796 4133

Charlie Jack, Nick Moore, Francesca Rosser

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFFLFAIEISESE
Date   Source Headline
4th Jun 20267:00 amRNSTransaction in Own Shares
3rd Jun 20267:00 amRNSTransaction in Own Shares
2nd Jun 20267:00 amRNSTransaction in Own Shares
1st Jun 20267:30 amRNSTotal Voting Rights
1st Jun 20267:00 amRNSTransaction in Own Shares
29th May 20267:00 amRNSTransaction in Own Shares
28th May 20267:00 amRNSTransaction in Own Shares
26th May 20262:42 pmRNSShare Buyback Programme
20th May 202611:26 amRNSIndonesian commodity exporting
12th May 20262:52 pmRNSAGM Arrangements
1st Apr 20265:40 pmRNS2025 Annual Report
26th Mar 202610:16 amRNSDirector/PDMR Shareholding
24th Mar 20267:00 amRNSFinal Results 2025
5th Mar 20267:00 amRNSNotice of Results
23rd Jan 20267:00 amRNSDirector/PDMR Shareholding
22nd Jan 20267:00 amRNS2025 Crop and production
16th Jan 20261:05 pmRNSDirector/PDMR Shareholding
6th Jan 20267:00 amRNSDirector/PDMR Shareholding
18th Dec 20257:00 amRNSDirector/PDMR Shareholding
16th Dec 20257:00 amRNSDirector/PDMR Shareholding
11th Dec 202512:58 pmRNSPublication of 2024 ESG report
2nd Dec 20251:14 pmRNSCompany update
1st Dec 20257:00 amRNSAppointment of joint broker
10th Nov 20257:00 amRNSStrong pricing during second half of 2025
28th Oct 20255:33 pmRNSHolding(s) in Company
22nd Sep 20253:26 pmRNSAIM Rule 20
15th Sep 20257:00 amRNSHalf-year Report
27th Aug 20257:00 amRNSNotice of interim results & investor presentation
29th Jul 20257:00 amRNSPublication of TCFD report
24th Jul 20257:00 amRNS2025 H1 crop and production
14th Jul 202510:07 amRNSAcquisition
7th Jul 20254:54 pmRNSDirector/PDMR Shareholding
30th Jun 20254:30 pmRNSTotal Voting Rights
25th Jun 202511:18 amRNSIssue of Equity
18th Jun 20257:00 amRNSShare buyback programme
13th Jun 20251:45 pmRNSResult of AGM
13th Jun 20257:00 amRNSAGM Statement
12th Jun 20254:50 pmRNSAppointment to board roles
5th Jun 20257:00 amRNSAGM update
14th May 20257:00 amRNSDirectorate Change
22nd Apr 20255:33 pmRNSDirector/PDMR Shareholding
16th Apr 202511:00 amRNSAcquisition
31st Mar 20254:02 pmRNSPosting of Annual Report
25th Mar 20257:00 amRNSFinal Results
21st Mar 20257:00 amRNSDirector retirement
5th Mar 20257:00 amRNSNotice of Results and investor presentation
20th Jan 20253:05 pmRNSDirector/PDMR Shareholding
20th Jan 20257:00 amRNSCrop and production
2nd Jan 202511:31 amRNSDirector/PDMR Shareholding
2nd Jan 20257:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.